← Back to Search

Behavioural Intervention

Improving Blood Pressure and Cardiovascular Risk With Resistance Exercise in African Americans (BPVR Trial)

N/A
Waitlist Available
Led By Shane Phillips, PhD
Research Sponsored by University of Illinois at Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial will test the effects of aerobic and resistance training on arterial stiffness, FMD, and gluteal adipose tissue in sedentary, overweight/obese women.

Eligible Conditions
  • High Blood Pressure
  • Chorioretinal Vascular Disease
  • Cardiovascular Disease
  • Vascular Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Resistance TrainingExperimental Treatment1 Intervention
Participants will undergo a supervised resistance training program in accordance with established guidelines. Each session will be monitored by a physical therapist or exercise physiologist. Sessions will be carried out 3 times per week, 45 min per session. Muscle strength will be determined once before and once after resistance training by measuring ten repetition maximum (10 RM) for each exercise. Eight exercises (three sets; 8-12 repetitions) will be used on each of the large muscle groups (leg press, leg extension, leg curl, chest press, shoulder extension, biceps curl, abdominal crunch and back extension). In addition, workloads will be progressively increased if the patients can lift the weight more than 12 repetitions.
Group II: Aerobic TrainingExperimental Treatment1 Intervention
Participants will undergo a supervised endurance training program in accordance with established guidelines. Each session will be monitored by a physical therapist or exercise physiologist. Sessions will be carried out 3 times per week. During each session, participants will complete a 5 min warm-up followed by 30-45 min of endurance exercise using cycle ergometry. Intensity will be monitored using heart rate monitors during each exercise session, and each participant will receive an exercise prescription with a heart range equivalent to 65-85% of their heart rate max. Participants will be asked to complete 30 min of exercise during each session in week 1, 35 min in week 2 and 40-45 min weeks 3-8 with a 5 min cool down period.

Find a Location

Who is running the clinical trial?

University of Illinois at ChicagoLead Sponsor
639 Previous Clinical Trials
1,568,646 Total Patients Enrolled
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,938 Previous Clinical Trials
47,792,158 Total Patients Enrolled
Shane Phillips, PhD4.749 ReviewsPrincipal Investigator - University of Illinois at Chicago
Medical School - University of North Texas
John Peter Smith Hospital, Residency in Family Medicine
5Patient Review
This was an excellent experience. I felt well-informed and like something was actually accomplished.
~15 spots leftby Dec 2025